glp 1 weight loss plateau All About the GLP-1 GLP-1 Weight Loss Plateau: Causes

Description

Diabetes Care 39:12411249 Magkos F, Fraterrigo G, Yoshino J et al (2016) Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity

regulators flagged severe and sometimes fatal pancreatitis cases in 2007-2008 for the earlier GLP-1 drug Byetta (exenatide) and advised clinicians to stop therapy if patients develop persistent severe abdominal pain radiating to the back In the United States, nearly 2,000 GLP-1 lawsuitsprimarily alleging severe gastrointestinal injuries (gastroparesis, bowel obstruction, related complications) after Ozempic, Wegovy, Mounjaro, Trulicity, and other agentsare centralized in federal Multidistrict Litigation (MDL No

Time-Restricted Eating (TRE) involves eating within a daily window, commonly: 16:8 (16-hour fast, 8-hour eating) 14:10 (easier to start) 12:12 (gentle beginning) Benefits of TRE: Reduces insulin exposure Promotes fat oxidation Improves appetite regulation Supports circadian rhythm Start with 12:12 , then extend as tolerated

Articles were included if they were published in the last 10 years, were written in the English language, and had a specific focus on the use of GLP-1 RAs in patients with psoriasis and/or HS

If youre considering or already taking GLP-1 medications, talk with your healthcare provider or a registered dietitian about developing a personalized plan